What is HDL Cholesterol? HDL cholesterol stands for high-density lipoprotein cholesterol, often called "good" cholesterol. Think of HDL as your body's cleanup crew for cholesterol. These tiny particles travel through your bloodstream, picking up excess cholesterol from your arteries and blood vessel walls and transporting it back to your liver, where it can be processed and removed from your body.[1]This process is called "reverse cholesterol transport."[2] Unlike LDL ("bad") cholesterol, which can build up in your arteries and contribute to blockages, HDL cholesterol works to remove cholesterol from places where it could cause harm. HDL also has other protective functions—it helps reduce inflammation in your blood vessels, prevents harmful oxidation of cholesterol, and may even help prevent blood clots.[2][3] How is HDL Cholesterol Measured? HDL cholesterol is measured through a simple blood test, usually as part of a standard lipid panel or cholesterol screening.[4][5] Your blood work includes measures of several types of cholesterol, including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. The test directly measures the amount of cholesterol carried by HDL particles in your blood.[4] Understanding Your HDL Cholesterol Numbers HDL cholesterol is measured in milligrams per deciliter (mg/dL) of blood. Here's what your numbers mean:[2][6] - Less than 40 mg/dL (men) or less than 50 mg/dL (women): Low HDL cholesterol, which increases your risk of heart disease - 40-59 mg/dL: Acceptable, but higher is generally better for heart protection - 60 mg/dL and above: Considered protective against heart disease Low HDL cholesterol is concerning because it's associated with increased cardiovascular risk in observational studies.[2][7] However, the relationship between HDL and heart health is more complex than once thought. While low HDL clearly correlates with increased risk, extremely high HDL levels (above 80 mg/dL in men or 100 mg/dL in women) may paradoxically be associated with increased health risks in some people.[8][9] This is why your doctor looks at your complete health picture, not just one number. It's also important to understand that HDL cholesterol often travels with other risk factors. Low HDL frequently occurs alongside insulin resistance, high triglycerides, obesity, smoking, and inflammation.[10] After accounting for these other factors, the independent contribution of HDL to cardiovascular risk becomes less clear.[11] This is one reason why attempts to raise HDL with medications have not reliably reduced heart attacks or strokes.[12][8][13] Why is HDL Cholesterol Testing Important?

Testing your HDL cholesterol remains a valuable part of assessing your cardiovascular risk for several important reasons:

1. It helps predict your heart disease risk. Multiple large studies have shown that HDL cholesterol levels correlate with heart attacks, strokes, and cardiovascular death.[2][10][14] Your HDL level, combined with other risk factors like your age, blood pressure, smoking status, and family history, helps your doctor calculate your overall cardiovascular risk.[13] 2. It provides a baseline for monitoring. Knowing your HDL level now establishes a baseline that you and your doctor can track over time to see if your prevention efforts are working. 3. It identifies opportunities for lifestyle changes. While raising HDL with medications hasn't proven beneficial, the lifestyle changes that improve HDL—like exercise, weight loss, and quitting smoking—reduce cardiovascular risk through multiple pathways beyond just changing your HDL number.[15][16][17] 4. It's part of your overall lipid profile. HDL is one piece of the puzzle. Your doctor uses it alongside LDL cholesterol, triglycerides, and other measures to understand your cardiovascular health comprehensively.[4][14] How Can You Improve Your HDL Cholesterol and Overall Heart Health? If your HDL cholesterol is low, several evidence-based lifestyle strategies can help improve your overall cardiovascular health. While these approaches may modestly raise HDL, their real benefit comes from reducing cardiovascular risk through multiple mechanisms:[18][15][16] Exercise regularly. Aerobic exercise is one of the most effective lifestyle interventions for cardiovascular health. Aim for at least 30 minutes of moderate exercise most days of the week, with total weekly exercise exceeding 120 minutes showing greater benefit. Exercise typically increases HDL by a modest 2-5 mg/dL, but more importantly, it improves cardiovascular fitness, reduces inflammation, and lowers overall heart disease risk.[15][16][19][20] Maintain a healthy weight. Losing excess weight, particularly around your midsection, can improve HDL levels and reduce cardiovascular risk. For every kilogram (2.2 pounds) of sustained weight loss, HDL cholesterol typically increases by about 0.35 mg/dL.[21] Quit smoking. Tobacco use lowers HDL cholesterol and impairs its protective functions. Quitting smoking can produce a modest increase in HDL and dramatically reduces your cardiovascular risk through many other pathways.[22] Choose healthy fats. Replace saturated fats and trans fats with healthier monounsaturated and polyunsaturated fats found in olive oil, nuts, avocados, and fatty fish. These dietary changes can improve your overall lipid profile and reduce cardiovascular risk.[22] Limit refined carbohydrates. Reducing intake of refined carbohydrates and sugars while increasing fiber can help improve your References 1. High-Density Lipoproteins, Reverse Cholesterol Transport and Atherogenesis. Pownall HJ, Rosales C, Gillard BK, Gotto AM. Nature Reviews. Cardiology. 2021;18(10):712-723. doi:10.1038/s41569-021-00538-z. 2. Low HDL Cholesterol Levels. Ashen MD, Blumenthal RS. The New England Journal of Medicine. 2005;353(12):1252-60. doi:10.1056/NEJMcp044370. 3. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy. Linton MF, Yancey PG, Tao H, Davies SS. Circulation Research. 2023;132(11):1521-1545. doi:10.1161/CIRCRESAHA.123.321563. 4. Lipid Measurements in the Management of Cardiovascular Diseases: Practical Recommendations a Scientific Statement From the National Lipid Association Writing Group. Wilson PWF, Jacobson TA, Martin SS, et al. Journal of Clinical Lipidology. 2021 Sep-Oct;15(5):629-648. doi:10.1016/j.jacl.2021.09.046. 5. A Test in Context: Lipid Profile, Fasting Versus Nonfasting. Nordestgaard BG. Journal of the American College of Cardiology. 2017;70(13):1637-1646. doi:10.1016/j.jacc.2017.08.006. 6. Cholesterol Levels. National Library of Medicine (MedlinePlus). 7. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis. Ahmed HM, Miller M, Nasir K, et al. American Journal of Epidemiology. 2016;183(10):875-83. doi:10.1093/aje/kwv305. 8. Does Elevated High-Density Lipoprotein Cholesterol Protect Against Cardiovascular Disease?. Razavi AC, Jain V, Grandhi GR, et al. The Journal of Clinical Endocrinology and Metabolism. 2024;109(2):321-332. doi:10.1210/clinem/dgad406. 9. Association Between High-Density Lipoprotein Cholesterol and the Risk of Cardiovascular Disorders: A Cohort Study of Healthy Adults. Park BE, Choi KU, Choi JY, et al. The American Journal of Cardiology. 2025;:S0002-9149(25)00630-7. doi:10.1016/j.amjcard.2025.10.004. 10. High-Density Lipoprotein Cholesterol And Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study. Ko DT, Alter DA, Guo H, et al. Journal of the American College of Cardiology. 2016;68(19):2073-2083. doi:10.1016/j.jacc.2016.08.038. 11. Race-Dependent Association of High-Density Lipoprotein Cholesterol Levels With Incident Coronary Artery Disease. Zakai NA, Minnier J, Safford MM, et al. Journal of the American College of Cardiology. 2022;80(22):2104-2115. doi:10.1016/j.jacc.2022.09.027. 12. Pharmacological Lipid-Modification Therapies for Prevention of Ischaemic Heart Disease: Current and Future Options. Ray KK, Corral P, Morales E, Nicholls SJ. Lancet (London, England). 2019;394(10199):697-708. doi:10.1016/S0140-6736(19)31950-6. 13. HDL and Cardiovascular Disease. Rader DJ, Hovingh GK. Lancet (London, England). 2014;384(9943):618-625. doi:10.1016/S0140-6736(14)61217-4. 14. Major Lipids, Apolipoproteins, and Risk of Vascular Disease. Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, et al. JAMA. 2009;302(18):1993-2000. doi:10.1001/jama.2009.1619. 15. Exercise for Primary and Secondary Prevention of Cardiovascular Disease: JACC Focus Seminar 1/4. Tucker WJ, Fegers-Wustrow I, Halle M, et al. Journal of the American College of Cardiology. 2022;80(11):1091-1106. doi:10.1016/j.jacc.2022.07.004. 16. Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Barone Gibbs B, Hivert MF, Jerome GJ, et al. Hypertension (Dallas, Tex. : 1979). 2021;78(2):e26-e37. doi:10.1161/HYP.0000000000000196. 17. A Clinician's Guide for Trending Cardiovascular Nutrition Controversies: Part II. Freeman AM, Morris PB, Aspry K, et al. Journal of the American College of Cardiology. 2018;72(5):553-568. doi:10.1016/j.jacc.2018.05.030. 18. Secondary Prevention After Coronary Artery Bypass Graft Surgery: A Scientific Statement From the American Heart Association. Kulik A, Ruel M, Jneid H, et al. Circulation. 2015;131(10):927-64. doi:10.1161/CIR.0000000000000182. 19. The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-Analysis. Smart NA, Downes D, van der Touw T, et al. Sports Medicine (Auckland, N.Z.). 2025;55(1):67-78. doi:10.1007/s40279-024-02115-z. 20. Exercise Standards for Testing and Training: A Scientific Statement From the American Heart Association. Fletcher GF, Ades PA, Kligfield P, et al. Circulation. 2013;128(8):873-934. doi:10.1161/CIR.0b013e31829b5b44. 21. Nonpharmacologic Management of Low Levels of High-Density Lipoprotein Cholesterol. Ginsberg HN. The American Journal of Cardiology. 2000;86(12A):41L-45L. doi:10.1016/s0002-9149(00)01469-7. 22. High-Density Lipoprotein as a Therapeutic Target: A Systematic Review. Singh IM, Shishehbor MH, Ansell BJ. JAMA. 2007;298(7):786-98. doi:10.1001/jama.298.7.786.